A detailed history of Fedenia Advisers LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fedenia Advisers LLC holds 126 shares of LLY stock, worth $102,196. This represents 0.06% of its overall portfolio holdings.

Number of Shares
126
Holding current value
$102,196
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$727.2 - $932.06 $91,627 - $117,439
126 New
126 $97.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fedenia Advisers LLC Portfolio

Follow Fedenia Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fedenia Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fedenia Advisers LLC with notifications on news.